Mariella E.C.J. Hassell

Showing 1-4 of 4 articles

Author Mariella E.C.J. Hassell

Coronary interventions

Microvascular dysfunction following ST-elevation myocardial infarction and its recovery over time

Hassell M, Bax M, van Lavieren M, Nijveldt R, Hirsch A, Robbers L, Marques K, Tijssen J, Zijlstra F, van Rossum A, Delewi R, Piek J

August 4, 2017 | 10.4244/EIJ-D-16-00818

Author Robin P. Kraak

Coronary interventions

Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria

Kraak R, Grundeken M.J, Hassell M, Elias J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Thijssen J, de Winter R, Wykrzykowska J

August 5, 2016 | 10.4244/EIJV12I5A95

Author Maik J. Grundeken

Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography

Grundeken M.J, Hassell M, Kraak R, de Bruin D, Koch K, Henriques J, van Leeuwen T, Thijssen J, Piek J, de Winter R, Wykrzykowska J

December 20, 2015 | 10.4244/EIJY14M08_15

Author Robin P. Kraak

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

Kraak R, Hassell M, Grundeken M.J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Arkenbout E, Thijssen J, de Winter R, Wykrzykowska J

February 20, 2015 | 10.4244/EIJY14M08_08

1

Latest news

Percutaneous recanalisation of CTO, FAST-TAVI trial, substudy from DANAMI-3-PRIMULTI... discover the latest issue

Computation of OFR by OCT on a LAD with physiologically non-significant stenosis.

Guidance papers

Clinical use of intracoronary imaging Part 2

Read this consensus to appraise ACS, ambiguous coronary angio findings and interventional decision-making

New this week: Hyperemic, Syntax and Optimum trials papers

The new Impact Factor is out!

EuroIntervention IF is 4.018

Special subscription offer!

Register before the end of August and save up to 40% on the regular rates

Guidance papers

Guidelines, consensus & position papers

Late breaking trials

Access the Late Breaking Trials published at EuroPCR 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke